AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20617889 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) to the posterior superior temporal gyrus (pSTG)
Number of subjects: 0
Study 20617889 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) to the middle temporal gyrus (MTG)
Number of subjects: 0
Study 19168857 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 120
Study 19168857 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 120
Study 17085348 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-knife cut
Number of subjects: 91
Study 17085348 — intervention group
Group type: COMPARATOR
Intervention: Persistent cannulation by standard techniques
Number of subjects: 91
Study 15339772 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (25-microg intravaginal dose)
Number of subjects: 68
Study 15339772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 10513186 — intervention group
Group type: EXPERIMENTAL
Intervention: LA with 2 ml of 1% lidocaine using a 24‐gauge needle
Number of subjects: 60
Study 10513186 — intervention group
Group type: EXPERIMENTAL
Intervention: LA with 0.5 ml of 1% lidocaine using a 27‐gauge needle
Number of subjects: 60
Study 10513186 — intervention group
Group type: COMPARATOR
Intervention: Without LA
Number of subjects: 60
Study 8655712 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested PCR
Number of subjects: 31
Study 8655712 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemistry
Number of subjects: 31
Study 8655712 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nested PCR and immunohistochemistry
Number of subjects: 31
Study 1517929 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone therapy for 12 weeks
Number of subjects: 20
Study 1517929 — intervention group
Group type: COMPARATOR
Intervention: Placebo dosing for 12 weeks
Number of subjects: 20
Study 6391140 — intervention group
Group type: EXPERIMENTAL
Intervention: VAP (vindesine, doxorubicin, and cisplatin)
Number of subjects: 105
Study 6391140 — intervention group
Group type: COMPARATOR
Intervention: VAP + thymosin
Number of subjects: 105
Study 6391140 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin treatment
Number of subjects: 105
Study 30690825 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) integrated with clinical assessment
Number of subjects: 518
Study 30690825 — intervention group
Group type: COMPARATOR
Intervention: Chest radiography (CXR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) integrated with clinical evaluation
Number of subjects: 518
Study 28756402 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured unsupervised home-based pulmonary rehabilitation programme
Number of subjects: 287
Study 28756402 — intervention group
Group type: COMPARATOR
Intervention: Centre-based supervised pulmonary rehabilitation
Number of subjects: 287
Study 27256936 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug Adherence Enhancement Program
Number of subjects: 56
Study 27256936 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study 23877730 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic technique
Number of subjects: 60
Study 23877730 — intervention group
Group type: COMPARATOR
Intervention: Minimal invasive open technique
Number of subjects: 60
Study 22031518 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic‐normoglycemic clamp technique with 24‐h preoperative carbohydrate load
Number of subjects: 30
Study 22031518 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose control through insulin sliding scale treatment
Number of subjects: 30
Study 22031518 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic‐normoglycemic clamp technique
Number of subjects: 30
Study 20141812 — intervention group
Group type: EXPERIMENTAL
Intervention: IPS e.max Press
Number of subjects: 48
Study 20141812 — intervention group
Group type: EXPERIMENTAL
Intervention: Procera AllCeram
Number of subjects: 48
Study 20141812 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal ceramic (Simidur S 2 veneered with IPS Classic Porcelain)
Number of subjects: 48
Study 20141812 — intervention group
Group type: COMPARATOR
Intervention: Control group (Procera AllCeram)
Number of subjects: 48
Study 19189517 — intervention group
Group type: EXPERIMENTAL
Intervention: Antismoking counseling by physicians
Number of subjects: 1267
Study 15733643 — intervention group
Group type: EXPERIMENTAL
Intervention: High treatment expectancy
Number of subjects: 105
Study 15733643 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking pain medication and poor functional status at baseline
Number of subjects: 105
Study 15733643 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg pain and back pain at baseline
Number of subjects: 105
Study 12660386 — intervention group
Group type: EXPERIMENTAL
Intervention: High-strength levorphanol (0.75 mg)
Number of subjects: 81
Study 12660386 — intervention group
Group type: COMPARATOR
Intervention: Low-strength levorphanol (0.15 mg)
Number of subjects: 81
Study 10713745 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat (HF) pre-load meal (55% of ADER)
Number of subjects: 12
Study 10713745 — intervention group
Group type: COMPARATOR
Intervention: Low-fat (LF) pre-load meal (20% of ADER)
Number of subjects: 12
Study 10713745 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum insulin concentration before eating the test meal
Number of subjects: 12
Study 8661977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (sCT) 50 IU
Number of subjects: 208
Study 8661977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (sCT) 100 IU
Number of subjects: 208
Study 8661977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (sCT) 200 IU
Number of subjects: 208
Study 8661977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 8661977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal salmon calcitonin (sCT) (all doses)
Number of subjects: 208
Study 1796850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BCG
Number of subjects: 84
Study 1796850 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral BCG
Number of subjects: 84
Study 1796850 — intervention group
Group type: COMPARATOR
Intervention: Control group (TUR-BT)
Number of subjects: 84
Study 6581174 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline therapy (daily for 50 weeks)
Number of subjects: 14
Study 6581174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 14
Study 31102793 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based virtual reality phone application
Number of subjects: 86
Study 31102793 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional education)
Number of subjects: 86
Study 28575910 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of colostrum (OAC)
Number of subjects: 30
Study 28575910 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 30
Study 27507112 — intervention group
Group type: EXPERIMENTAL
Intervention: New or persistent hypochloremia at day 14
Number of subjects: 1960
Study 27507112 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hypochloremia that resolved by day 14
Number of subjects: 1960
Study 27507112 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloride measured at day 14
Number of subjects: 1960
Study 27507112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline chloride
Number of subjects: 1960
Study 24850938 — intervention group
Group type: EXPERIMENTAL
Intervention: Online simulated-patient case (virtual-patient group)
Number of subjects: 0
Study 24850938 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty‐led problem‐based learning (PBL group)
Number of subjects: 0
Study 24850938 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the PBL group)
Number of subjects: 0
Study 22880805 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of cefazolin sodium intravenously 1 h prior to catheter insertion
Number of subjects: 60
Study 22880805 — intervention group
Group type: COMPARATOR
Intervention: Saline intravenously 1 h prior to catheter insertion
Number of subjects: 60
Study 20438307 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 939
Study 20438307 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based regimens
Number of subjects: 939
Study 18978105 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-microgram E2 vaginal tablets
Number of subjects: 309
Study 18978105 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal tablets
Number of subjects: 309
Study 16085584 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐tetrofosmin uptake after nitrate administration
Number of subjects: 21
Study 16085584 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐tetrofosmin perfusion defect severity after nitrate administration
Number of subjects: 21
Study 16085584 — intervention group
Group type: EXPERIMENTAL
Intervention: ceMRI cutoff below 40%
Number of subjects: 21
Study 16085584 — intervention group
Group type: COMPARATOR
Intervention: (99m)Tc‐tetrofosmin uptake at rest
Number of subjects: 21
Study 16085584 — intervention group
Group type: COMPARATOR
Intervention: (99m)Tc‐tetrofosmin perfusion defect severity at rest
Number of subjects: 21
Study 11910262 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine at 20 mg/day for 10 days
Number of subjects: 45
Study 11910262 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline at 50 mg/day for 3 days, followed by 100 mg/day for 10 days
Number of subjects: 45
Study 11910262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine at 20 mg/day for 28 days
Number of subjects: 45
Study 10327575 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine substitution
Number of subjects: 34
Study 10327575 — intervention group
Group type: COMPARATOR
Intervention: Control (without glutamine)
Number of subjects: 34
Study 8417217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional purified clostridial collagenase
Number of subjects: 49
Study 8417217 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 49
Study 3529911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide (up to 2 mg/kg intravenously and then orally)
Number of subjects: 60
Study 3529911 — intervention group
Group type: COMPARATOR
Intervention: Quinidine (up to 1.2 g orally)
Number of subjects: 60
Study 3529911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 60
Study 3529911 — intervention group
Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 60
Study 29294954 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting program (Healthy Families Massachusetts)
Number of subjects: 448
Study 29294954 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 448
Study 31567611 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 40 U
Number of subjects: 865
Study 31567611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 865
Study 30376747 — intervention group
Group type: EXPERIMENTAL
Intervention: High BMI / High NP
Number of subjects: 997
Study 30376747 — intervention group
Group type: COMPARATOR
Intervention: Low BMI / Low NP
Number of subjects: 997
Study 30376747 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher NP levels
Number of subjects: 997
Study 30376747 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI around 25 kg/m2
Number of subjects: 997
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 10 mg
Number of subjects: 0
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 30 mg
Number of subjects: 0
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 60 mg
Number of subjects: 0
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 2.5 mg
Number of subjects: 0
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021 20 mg
Number of subjects: 0
Study 26681715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26681715 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2409021
Number of subjects: 0
Study 26664304 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 160 mg loading dose followed by 80 mg daily
Number of subjects: 140
Study 26664304 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg daily
Number of subjects: 140
Study 26664304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 140
Study 23749418 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected adults
Number of subjects: 0
Study 23749418 — intervention group
Group type: COMPARATOR
Intervention: Matched uninfected control group
Number of subjects: 0
Study 22299547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu LMA
Number of subjects: 118
Study 22299547 — intervention group
Group type: COMPARATOR
Intervention: Classic LMA
Number of subjects: 118
Study 19903982 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg, 1 week)
Number of subjects: 10
Study 19903982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 17037645 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals who reported prior out-of-body experiences (N=9)
Number of subjects: 40
Study 17037645 — intervention group
Group type: COMPARATOR
Intervention: Individuals who did not report prior out-of-body experiences (N=31)
Number of subjects: 40
Study 17037645 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals who reported out-of-body experiences during the task (N=6)
Number of subjects: 40
Study 17037645 — intervention group
Group type: COMPARATOR
Intervention: Individuals who did not report out-of-body experiences during the task (N=34)
Number of subjects: 40
Study 12916666 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow cytometric tetraploidy and aneuploidy
Number of subjects: 0
Study 12916666 — intervention group
Group type: COMPARATOR
Intervention: Dysplasia grade
Number of subjects: 0
Study 12916666 — intervention group
Group type: EXPERIMENTAL
Intervention: 17p (p53) LOH
Number of subjects: 0
Study 11041004 — intervention group
Group type: EXPERIMENTAL
Intervention: Accountability for stock investment decision
Number of subjects: 0
Study 11041004 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterfactual excuse-making
Number of subjects: 0
Study 9680899 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% delmopinol hydrochloride
Number of subjects: 162
Study 9680899 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine digluconate
Number of subjects: 162
Study 9680899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 7770141 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-wash system
Number of subjects: 9
Study 7770141 — intervention group
Group type: COMPARATOR
Intervention: Wash system (Cell Saver Haemolite 2)
Number of subjects: 9
Study 3364403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca citrate (750 mg)
Number of subjects: 8
Study 3364403 — intervention group
Group type: COMPARATOR
Intervention: Ca(H2PO4)2 (750 mg)
Number of subjects: 8
Study 31021159 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated feeding tube attachment device (FTAD)
Number of subjects: 104
Study 31021159 — intervention group
Group type: COMPARATOR
Intervention: Adhesive tape
Number of subjects: 104
Study 27709360 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocopherol-enriched Mediterranean meal (TEM)
Number of subjects: 0
Study 27709360 — intervention group
Group type: COMPARATOR
Intervention: Western high-fat meal (HFM)
Number of subjects: 0
Study 27709360 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 0
Study 25359444 — intervention group
Group type: COMPARATOR
Intervention: Control (fifteen 40‐minute sessions of transcutaneous electrical nerve stimulation, microwave treatment, and standardized exercises)
Number of subjects: 461
Study 25359444 — intervention group
Group type: EXPERIMENTAL
Intervention: GDS‐I (eleven 50‐minute group GDS sessions plus four 50‐minute individualized GDS sessions)
Number of subjects: 461
Study 25359444 — intervention group
Group type: EXPERIMENTAL
Intervention: GDS‐G (eleven 50‐minute group GDS sessions)
Number of subjects: 461
Study 23771800 — intervention group
Group type: EXPERIMENTAL
Intervention: PM00104 (Zalypsis) administered as a 1-h, weekly, intravenous infusion at a dose of 2 mg/m2 (days 1, 8, and 15; every 4 weeks)
Number of subjects: 19
Study 21398178 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic stenting
Number of subjects: 98
Study 21398178 — intervention group
Group type: COMPARATOR
Intervention: Emergency surgery
Number of subjects: 98
Study 18804943 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortobifemoral bypass (ABF)
Number of subjects: 169
Study 18804943 — intervention group
Group type: COMPARATOR
Intervention: Recanalization, percutaneous transluminal angioplasty, and stenting (R/PTAS)
Number of subjects: 169
Study 16551142 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug court with usual community services
Number of subjects: 161
Study 16551142 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug court with multisystemic therapy
Number of subjects: 161
Study 16551142 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug court with multisystemic therapy enhanced with contingency management
Number of subjects: 161
Study 16551142 — intervention group
Group type: COMPARATOR
Intervention: Family court with usual community services
Number of subjects: 161
Study 14607573 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) and zinc sulfate (66 mg)
Number of subjects: 190
Study 14607573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 10892657 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (20-g oral dose)
Number of subjects: 18
Study 10892657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8930680 — intervention group
Group type: EXPERIMENTAL
Intervention: Test mouthrinse containing sodium benzoate and alcohol
Number of subjects: 20
Study 8930680 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 20
Study 8930680 — intervention group
Group type: EXPERIMENTAL
Intervention: Test mouthrinse
Number of subjects: 20
Study 8018144 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (100 mg twice weekly)
Number of subjects: 278
Study 8018144 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized pentamidine (100 mg every 2 weeks)
Number of subjects: 278
Study 8018144 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine therapy
Number of subjects: 278
Study 3915459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg b.i.d.)
Number of subjects: 45
Study 3915459 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone maleate (20 mg t.i.d.)
Number of subjects: 45
Study 3915459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine + Domperidone maleate
Number of subjects: 45
Study 29439618 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged GnRH agonist therapy (3 consecutive IM injections of triptorelin 3.75 mg 28 days apart)
Number of subjects: 90
Study 29439618 — intervention group
Group type: COMPARATOR
Intervention: Standard long protocol
Number of subjects: 90
Study 27159342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 32
Study 27159342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 24166711 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=8 departments)
Number of subjects: 293
Study 24166711 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=7 departments)
Number of subjects: 293
Study 23544775 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for depression (specifics not provided, but benzodiazepines were used in 18% of patients)
Number of subjects: 100
Study 23544775 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study 19660890 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letters
Number of subjects: 1499
Study 19660890 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-delivered brief advice
Number of subjects: 1499
Study 19660890 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 1499
Study 17655565 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy (YT)
Number of subjects: 61
Study 17655565 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise therapy (PT)
Number of subjects: 61
Study 16101703 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound prelocation (UL) using a TEE intraoperative probe
Number of subjects: 62
Study 16101703 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmark method (AL)
Number of subjects: 62
Study 12098160 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic activity of the VMO and vastus lateralis during rise task and rock task
Number of subjects: 74
Study 10070170 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril (20 mg/day)
Number of subjects: 20
Study 10070170 — intervention group
Group type: EXPERIMENTAL
Intervention: irbesartan (100 mg/day)
Number of subjects: 20
Study 7717738 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizotifen
Number of subjects: 14
Study 7717738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 1646106 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonium chloride (NH4Cl) ingestion
Number of subjects: 18
Study 1646106 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) ingestion
Number of subjects: 18
Study 298341 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-endorphin
Number of subjects: 1
Study 298341 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 1
Study 298341 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 1
Study 31517505 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion parameters (proportion of perfused capillaries)
Number of subjects: 66
Study 31517505 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcirculatory perfusion parameters (perfused capillary density)
Number of subjects: 66